Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer

US Patent 10077261 · Granted Sep 18, 2018

Estimated economic value: $145,875,000

Assignee

Inventors

View full patent text on Google Patents →